NCT06823947View on ClinicalTrials.gov

Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension

PHASE1RecruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

April 3, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Healthy Volunteers Essential Hypertension
Interventions
DRUG

Placebo

Placebo is administered single dose or multiple dose by SC injection.

DRUG

KK3910

KK3910 is administered single dose or multiple dose by SC injection.

Trial Locations (1)

Unknown

RECRUITING

Kitasato University Kitasato Institute Hospital, Minato-ku

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY